Heron Therapeutics Inc — Cash Flow (NASDAQ:HRTX) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 184.82 M203.35 M146.91 M58.79 M22.53 M27.59 M 27.59 M Cash from investing activities 208.96 M32.73 M3.32 M18 M18.71 M16.01 M 16.01 M Cash from financing activities 9.11 M156.03 M75.06 M54.11 M940 K14.43 M 14.43 M Free cash flow 178.01 M200.33 M145.09 M57.24 M20.82 M27.27 M 27.27 M

新闻

Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript

Heron Therapeutics Q4 每股收益逊于预期, 营收超出预期

Heron Therapeuti earnings missed, revenue topped estimates

Heron 2025年第四季度业绩:急症护理需求激增推动ZYNRELEF增长48%

Heron Q4 2025 slides: acute care surge drives 48% ZYNRELEF growth

海伦治疗公司股价因强劲的第四季度收入增长而飙升

Heron Therapeutics stock soars after strong Q4 revenue growth

海伦治疗公司的APONVIE在新术后恶心指南中获得推荐

Heron’s APONVIE featured in new postoperative nausea guidelines

Jefferies下调Heron Therapeutics股票目标价，因肿瘤业务下滑

Jefferies lowers Heron Therapeutics stock price target on oncology franchise decline

Heron Therapeutics, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:HRTX) 2025-11-04